WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer

British Journal of Pharmacology

Volumn 174, Issue 24, 2017, Pages 4547-4563

  Driehuis, Else ^a,b   Clevers, Hans ^a,b,c  

^a HUBRECHT INSTITUTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Princess Maxime Center (PMC)   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL RECEPTOR; CHROMOSOME PROTEIN; DICKKOPF 1 PROTEIN; FZD RECEPTOR; G PROTEIN COUPLED RECEPTOR; LGR5 PROTEIN; NOTUM PROTEIN; PROTEIN GPR124; PROTEIN NORRIN; RNF43 PROTEIN; RSPO PROTEIN; SCLEROSTIN; SECRETED FRIZZLED RELATED PROTEIN 1; TIKI PROTEIN; UNCLASSIFIED DRUG; WISE PROTEIN; WNT INHIBITORY PROTEIN 1; ANTINEOPLASTIC AGENT;

CANCER THERAPY; CELL MEMBRANE; CELL MIGRATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; WNT SIGNALING; ANIMAL; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL MEMBRANE; HUMANS; NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 85017356443     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13758     Document Type: Review

References (227)

1. Abarzua F (2005). Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617–9622.
2. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J et al. (2006). Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25: 4116–4121.
3. Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW et al. (2006). Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis 27: 1341–1348.
4. Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJM et al. (2002). The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum Mol Genet 11: 1549–1560.
5. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
6. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
7. Alexandre C, Baena-Lopez A, Vincent J-P (2014). Patterning and growth control by membrane-tethered Wingless. Nature 505: 180–185.
8. Anderson KD, Pan L, Yang X, Hughes VC, Walls JR, Dominguez MG et al. (2011). Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. PNAS 108: 2807–2812.
9. Assie G, Letouze E, Fassnacht M, Jouinot A, Luscap W, Barreau O et al. (2014). Integrated genomic characterization of adrenocortical carcinoma. Nat Genet 46: 607–612.
10. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA (1999). Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem 274: 16180–16187.
11. Bafico A, Liu GZ, Yaniv A, Gazit A, Aaronson SA (2001). Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol 3: 683–686.
12. Bänziger C, Soldini D, Schütt C, Zipperlen P, Hausmann G, Basler K (2006). Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125: 509–522.
13. Barker N, Clevers H (2006). Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5: 997–1014.
14. Bartscherer K, Pelte N, Ingelfinger D, Boutros M (2006). Secretion of Wnt ligands requires Evi, a conserved TransmembranProtein. Cell 125: 523–533.
15. Bazan JF, MacDonald B, He X (2013). The TIKI/TraB/PrgY family: a common protease fold for cell signaling from bacteria to metazoa. Dev Cell 25: 225–227.
16. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R et al. (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638–642.
17. Benhaj K, Akcali KC, Ozturk M (2006). Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15: 701–707.
18. Berndt T, Kumar R (2007). Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol 289: 1170–1182.
19. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP et al. (1996). A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382: 225–230.
20. Bodine PVN, Stauffer B, Ponce-de-Leon H, Bhat RA, Mangine A, Seestaller-Wehr LM et al. (2009). A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation. Bone 44: 1063–1068.
21. Bodine PVN, Zhao W, Kharode YP, Bex FJ, Lambert A-J, Goad MB et al. (2004). The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18: 1222–1237.
22. Brott BK, Sokol SY (2002). Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol 22: 6100–1610.
23. MacDonald BT, Tamai K, He X (2010). Wnt/b-catenin signaling: components, mechanisms, and diseases. Dev Biol 17: 9–26.
24. Cabrera CV, Alonso MC, Johnston P, Phillips RG, Lawrence PA (1987). Phenocopies induced with antisense RNA identify the wingless gene. Cell 50: 659–663.
25. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P et al. (2004). The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64: 883–888.
26. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q (2011). R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. PNAS 108: 11452–11457.
27. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, Croix BS (2001). Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61: 6649–6655.
28. Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H et al. (1998). Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 395: 604–608.
29. Chartier C, Raval J, Axelrod F, Bond C, Cain J, Dee-Hoskins C et al. (2016). Therapeutic targeting of tumor-derived r-spondin attenuates b-catenin signaling and tumorigenesis in multiple cancer types. Cancer Res 76: 713–723.
30. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan C-W et al. (2009). Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100–107.
31. Chen PH, Chen X, Lin Z, Fang D, He X (2013). The structural basis of R-spondin recognition by LGR5 and RNF43. Genes Dev 27: 1345–1350.
32. Chung TKH, Lau TS, Cheung TH, Yim SF, Lo KWK, Siu NSS et al. (2012). Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 130: 1036–1045.
33. Clevers H (2006). Wnt/β-catenin signaling in development and disease. Cell 127: 469–480.
34. Clevers H, Loh KM, Nusse R (2014). Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 346: 54.
35. Clevers H, Nusse R (2012). Wnt/β-catenin signaling and disease. Cell 149: 1192–1205.
36. Colucci S, Brunetti G, Oranger A, Mori G, Sardone F, Specchia G et al. (2011). Myeloma cells suppress osteoblasts through sclerostin secretion. Blood Cancer J 1: e27.
37. Coombs GS, Yu J, Canning CA, Veltri CA, Covey TM, Cheong JK et al. (2010). WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification. J Cell Sci 123: 3357–3367.
38. Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S et al. (2016). Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375: 1532–1543.
39. Croix BS (2000). Genes expressed in human tumor endothelium. Science 289: 1197–1202.
40. Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY et al. (2011). GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. PNAS 108: 5759–5764.
41. Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, Leahy DJ (2001). Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412: 86–90.
42. DeAlmeida VI, Miao L, Ernst JA, Koeppen H, Polakis P, Rubinfeld B (2007). The soluble Wnt receptor Frizzled 8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Res 67: 5371–5379.
43. Deng B, Zhang Y, Zhang S, Wen F, Miao Y, Guo K (2015). MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7. Tumour Biol 36: 8065–8073.
44. Du G, Kataoka K, Sakaguchi M, Abarzua F, Than SS, Sonegawa H et al. (2011). Expression of REIC/Dkk-3 in normal and hyperproliferative epidermis. Exp Dermatol 20: 273–277.
45. Eaton S (2006). Release and trafficking of lipid-linked morphogens. Curr Opin Genet Dev 16: 17–22.
46. Egger-Adam D, Katanaev VL (2010). The trimeric G protein Go inflicts a double impact on axin in the Wnt/Frizzled signaling pathway. Dev Dyn 239: 168–183.
47. Farin HF, Jordens I, Mosa MH, Basak O, Korving J, Tauriello DVF et al. (2016). Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature 530: 340–354.
48. Galli LM, Barnes TL, Secrest SS, Kadowaki T, Burrus LW (2007). Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube. Development 134: 3339–3348.
49. Garcia-Fontana B, Morales-Santana S, Varsavsky M, Garcia-Martín A, Garcia-Salcedo JA, Reyes-Garcia R et al. (2014). Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids. Osteoporos Int 25: 645–651.
50. Geng Y, Lu X, Wu X, Xue L, Wang X, Xu J (2016). MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7. Oncol Rep 35: 2441–2450.
51. Gerlitz O, Basler K (2002). Wingful, an extracellular feedback inhibitor of Wingless. Genes Dev 16: 1055–1059.
52. Giannakis M, Hodis E, Jasmine Mu X, Yamauchi M, Rosenbluh J, Cibulskis K et al. (2014). RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet 46: 1264–1266.
53. Gilman AG (1987). G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56: 615–649.
54. Giráldez AJ, Copley RR, Cohen SM (2002). HSPG modification by the secreted enzyme Notum shapes the Wingless morphogen gradient. Dev Cell 2: 667–676.
55. Gkotzamanidou M, Dimopoulos MA, Kastritis E, Christoulas D, Moulopoulos LA, Terpos E (2012). Sclerostin: a possible target for the management of cancer-induced bone disease. Expert Opin Ther Targets 16: 761–769.
56. Glantschnig H, Scott K, Hampton R, Wei N, McCracken P, Nantermet P et al. (2011). A rate-limiting role for Dickkopf-1 in bone formation and the remediation of bone loss in mouse and primate models of postmenopausal osteoporosis by an experimental therapeutic antibody. J Pharmacol Exp Ther 338: 568–578.
57. Glinka A, Dolde C, Kirsch N, Huang Y-L, Kazanskaya O, Ingelfinger D et al. (2011). LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep 12: 1055–1061.
58. Goldstein B, Takeshita H, Mizumoto K, Sawa H (2006). Wnt signals can function as positional cues in establishing cell polarity. Dev Cell 10: 391–396.
59. Gong Y, Bourhis E, Chiu C, Stawicki S, Dealmeida VI, Liu BY et al. (2010). Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies. PLoS One 5: 1–17.
60. Goodman RM, Thombre S, Firtina Z, Gray D, Betts D, Roebuck J et al. (2006). Sprinter: a novel transmembrane protein required for Wg secretion and signaling. Development 133: 4901–4911.
61. Guidato S, Itasaki N (2007). Wise retained in the endoplasmic reticulum inhibits Wnt signaling by reducing cell surface LRP6. Dev Biol 310: 250–263.
62. Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L et al. (2012). Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci U S A 109: 11717–11722.
63. Halleskog C, Schulte G (2013). Pertussis toxin-sensitive heterotrimeric G(alphai/o) proteins mediate WNT/beta-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A. Cell Signal 25: 822–828.
64. Hao H-X, Xie Y, Zhang Y, Charlat O, Oster E, Avello M et al. (2012). ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485: 195–200.
65. Hayashi T, Asano H, Toyooka S, Tsukuda K, Soh J, Shien T et al. (2012). DNA methylation status of REIC/Dkk-3 gene in human malignancies. J Cancer Res Clin Oncol 138: 799–809.
66. He B, Reguart N, You L, Mazieres J, Xu Z, Lee AY et al. (2005). Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24: 3054–3058.
67. Hemler ME (2005). Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6: 801–811.
68. van den Heuvel M, Harryman-Samos C, Klingensmith J, Perrimon N, Nusse R (1993). Mutations in the segment polarity genes wingless and porcupine impair secretion of the wingless protein. EMBO J 12: 5293–5302.
69. van den Heuvel M, Nusse R, Johnston P, Lawrence PA (1989). Distribution of the wingless gene product in drosophila embryos: a protein involved in cell-cell communication. Cell 59: 739–749.
70. Ho SY, Keller TH (2015). The use of porcupine inhibitors to target Wnt-driven cancers. Bioorg Med Chem Lett 25: 5472–5476.
71. Hoffman K (2000). A superfamily of membrane-bound O-acetyltansferases with implications for Wnt signalling. Trends Biochem Sci 25: 112.
72. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T (2002). Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 55: 220–226.
73. Holstein TW, Watanabe H, Özbek S (2011). Signaling pathways and axis formation in the lower metazoa.
74. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH et al. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398: 431–436.
75. Hsieh S-Y, Hsieh P-S, Chiu C-T, Chen W-Y (2004). Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 23: 9183–9189.
76. Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martínez-Ansó E et al. (2009). Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 69: 6951–6959.
77. Huang Y, Anvarian Z, Döderlein G, Acebron SP, Niehrs C (2015). Maternal Wnt/STOP signaling promotes cell division during early Xenopus embryogenesis. Proc Natl Acad Sci U S A 112: 5732–5737.
78. Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC et al. (2003). Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130: 4295–4305.
79. Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC (2012). Structural basis of Wnt recognition by Frizzled. Science 337: 59–64.
80. Jho E, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F (2002). Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172–1183.
81. Jiang X, Charlat O, Zamponi R, Yang Y, Cong F (2015). Dishevelled promotes wnt receptor degradation through recruitment of znrf3/rnf43 e3ubiquitin ligases. Mol Cell 58: 522–533.
82. Jiang X, Hao H-X, Growney JD, Woolfenden S, Bottiglio C, Ng N et al. (2013). Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. PNAS 110: 12649–12654.
83. Jones SE, Jomary C (2002). Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays 24: 811–820.
84. Jones SE, Jomary C, Grist J, Stewart HJ, Neal MJ (2000). Modulated expression of secreted frizzled-related proteins in human retinal degeneration. Neuroreport 11: 3963–3967.
85. Junge HJ, Yang S, Burton JB, Paes K, Shu X, French DM et al. (2009). TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/β-catenin signaling. Cell 139: 299–311.
86. Kadowaki T, Wilder E, Klingensmith J, Zachary K, Perrimon N (1996). The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev 10: 3116–3128.
87. Kahn M (2014). Can we safely target the WNT pathway? Nat Rev Drug Discov 13: 513–532.
88. Kakugawa S, Langton PF, Zebisch M, Howell SA, Chang T-H, Liu Y et al. (2015). Notum deacylates Wnt proteins to suppress signalling activity. Nature 519: 187–192.
89. Katanaev VL, Ponzielli R, Sémériva M, Tomlinson A (2005). Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120: 111–122.
90. Katanaev VL, Solis GP, Hausmann G, Buestorf S, Katanayeva N, Schrock Y et al. (2008). Reggie-1/flotillin-2 promotes secretion of the long-range signalling forms of Wingless and Hedgehog in Drosophila. EMBO J 27: 509–521.
91. Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S et al. (2009). Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res 69: 8603–8610.
92. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R (2008). DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer 123: 535–542.
93. Kawano Y, Kypta R (2003). Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627–2634.
94. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y et al. (2009). REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 1658: 65–72.
95. Kazanskaya O, Glinka A, del Barco Barrantes I, Stannek P, Niehrs C, Wu W (2004). R-Spondin2 is a secreted activator of Wnt/β-catenin signaling and is required for Xenopus myogenesis. Dev Cell 7: 525–534.
96. Ke J, Harikumar KG, Erice C, Chen C, Gu X, Wang L et al. (2013). Structure and function of Norrin in assembly and activation of a Frizzled 4-Lrp5/6 complex. Genes Dev 27: 2305–2319.
97. Kerekes K, Banyai L, Patthy L (2015). Wnts grasp the WIF domain of Wnt Inhibitory Factor 1 at two distinct binding sites. FEBS Lett 589: 3044–3051.
98. Kikuchi A, Yamamoto H, Sato A, Matsumoto S (2011). New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 291: 21–71.
99. Kinzler K, Nilbert M, Su L, Vogelstein B, Bryan T, Levy D et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science 253: 661–665.
100. Knoblich K, Wang HX, Sharma C, Fletcher AL, Turley SJ, Hemler ME (2014). Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation. Cell Mol Life Sci 71: 1305–1314.
101. Komekado H, Yamamoto H, Chiba T, Kikuchi A (2007). Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes Cells 12: 521–534.
102. Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M et al. (2012). Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488: 665–669.
103. Kopein D, Katanaev VL (2009). Drosophila GoLoco-protein Pins is a target of Galpha(o)-mediated G protein-coupled receptor signaling. Mol Biol Cell 20: 3865–3877.
104. Koval A, Katanaev VL (2011). Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins. Biochem J 433: 435–440.
105. Koval A, Purvanov V, Egger-Adam D, Katanaev VL (2011). Yellow submarine of the Wnt/Frizzled signaling: submerging from the G protein harbor to the targets. Biochem Pharmacol 82: 1311–1319.
106. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L et al. (1999). Functional and structural diversity of the human Dickkopf gene family. Gene 238: 301–313.
107. Krutzfeldt J, Rosch N, Hausser J, Manoharan M, Zavolan M, Stoffel M (2012). MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1alpha) in adult liver and controls expression of frizzled-6. Hepatology 55: 98–107.
108. Kuhnert F, Mancuso MR, Shamloo A, Wang H-T, Choksi V, Florek M et al. (2010). Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124. Science 330: 985–959.
109. Kurose K, Sakaguchi M, Nasu Y, Erbara S, Kaku H, Kariyama R et al. (2004). Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 171: 1314–1318.
110. de Lau W, Barker N, Low TY, Koo B-K, Li VSW, Teunissen H et al. (2011). Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476: 293–297.
111. De Lau WBM, Snel B, Clevers HC (2012). The R-spondin protein family. Genome Biol 13: 1–10.
112. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S et al. (2000). Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220–3224.
113. Leyns L, Bouwmeester T, Kim SH, Piccolo S, De Robertis EM (1997). Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 88: 747–756.
114. Li N, Mao J, Sun L, Liu W, Wu D (2002). Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. J Biol Chem 277: 5977–5981.
115. Li VSW, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP et al. (2012). Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell 149: 1245–1256.
116. Li X, Ominsky MS, Warmington KS, Morony S, Gong J, Cao J et al. (2009). Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res 24: 578–588.
117. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J et al. (2005). Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280: 19883–19887.
118. Li Z, Chen P, Su R, Li Y, Hu C, Wang Y et al. (2015). Overexpression and knockout of miR-126 both promote leukemogenesis. Blood 126: 2005–2015.
119. Lintern KB, Guidato S, Rowe A, Saldanha JW, Itasaki N (2009). Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals. J Biol Chem 284: 23159–23168.
120. Liu T (2001). G protein signaling from activated rat Frizzled-1 to the beta -catenin-Lef-Tcf pathway. Science 292: 1718–1722.
121. Lowther W, Wiley K, Smith GH, Callahan R (2005). A new common integration site, Int7, for the mouse mammary tumor virus in mouse mammary tumors identifies a gene whose product has furin-like and thrombospondin-like sequences. J Virol 79: 10093–10096.
122. MacDonald BT, Hien A, Zhang X, Iranloye O, Virshup DM, Waterman ML et al. (2014). Disulfide bond requirements for active Wnt ligands. J Biol Chem 289: 18122–18136.
123. MacNabb C, Patton D, Hayes JS (2016). Sclerostin antibody therapy for the treatment of osteoporosis : clinical prospects and challenges. J Osteoporos 2016. https://doi.org/10.1155/2016/6217286.
124. Madan B, Ke Z, Lei ZD, Oliver FA, Lee MA, Rozen S et al. (2016). NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition. Oncotarget 7: 12386–12392.
125. Madan B, Virshup DM (2015). Targeting Wnts at the source—New mechanisms, new biomarkers. New Drugs Mol Cancer Ther : 1087–1095.
126. Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY (2011). Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 18: 886–893.
127. Malinauskas T, Jones EY (2014). Extracellular modulators of Wnt signalling. Curr Opin Struct Biol 29: 77–84.
128. Mao B, Niehrs C (2003). Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302: 179–183.
129. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM et al. (2002). Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417: 664–667.
130. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A et al. (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321–325.
131. Mendoza-Villanueva D, Zeef L, Shore P (2011). Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res 13: R106.
132. Mihara E, Hirai H, Yamamoto H, Tamura-Kawakami K, Matano M, Kikuchi A et al. (2016). Active and water-soluble form of lipidated wnt protein is maintained by a serum glycoprotein afamin/α-albumin. Elife 5: 1–19.
133. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V et al. (1996). XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86: 391–399.
134. Morrell NT, Leucht P, Zhao L, Kim JB, ten Berge D, Ponnusamy K et al. (2008). Liposomal packaging generates Wnt protein with in vivo biological activity. PLoS One 3: e2930.
135. Mulligan KA, Fuerer C, Ching W, Fish M, Willert K, Nusse R (2012). Inaugural Article: Secreted Wingless-interacting molecule (Swim) promotes long-range signaling by maintaining Wingless solubility. Proc Natl Acad Sci 109: 370–377.
136. Nakamura T, Aoki S, Kitajima K, Takahashi T, Matsumoto K, Nakamura T (2001). Molecular cloning and characterization of Kremen, a novel kringle-containing transmembrane protein. Biochim Biophys Acta-Gene Struct Expr 1518: 63–72.
137. Neumann CJ, Cohen SM (1997). Long-range action of Wingless organizes the dorsal-ventral axis of the Drosophila wing. Development 124: 871–880.
138. Niehrs C (2006). Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469–7481.
139. Niehrs C (2012). The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13: 767–779.
140. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A et al. (1991). Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665–659.
141. Noordermeer J, Klingensmith J, Perrimon N, Nusse R (1994). Dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature 367: 80–83.
142. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M et al. (2001). Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 19: 117–121.
143. Nusse R, Varmus HE (1982). Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31: 99–109.
144. Nüsslein-Volhard C, Wieschaus E (1980). Mutations affecting segment number and polarity in Drosophila. Nature 287: 795–801.
145. Ominsky MS, Vlasseros F, Jolette J, Smith SY, Stouch B, Doellgast G et al. (2010). Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 25: 948–959.
146. Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W et al. (2012). Exome sequencing of liver fluke–associated cholangiocarcinoma. Nat Genet 44: 690–693.
147. Padhi D, Jang G, Stouch B, Fang L, Posvar E (2011). Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res 26: 19–26.
148. Panáková D, Sprong H, Marois E, Thiele C, Eaton S (2005). Lipoprotein particles are required for Hedgehog and Wingless signalling. Nature 435: 58–65.
149. Peifer M, Sweeton D, Casey M, Wieschaus E (1994). wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development 120: 369–380.
150. Peng WC, deLau W, Forneris F, Granneman JCM, Huch M, Clevers H et al. (2013a). Structure of stem cell growth factor R-spondin 1 in complex with the ectodomain of its receptor LGR5. Cell Rep 3: 1885–1892.
151. Peng WC, Lau W, Madoori PK, Forneris F, Granneman JCM, Clevers H et al. (2013b). Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling. PLoS One 8, e83110.
152. Petersen CP, Reddien PW (2009). Wnt signaling and the polarity of the primary body axis. Cell 139: 1056–1068.
153. Phesse T, Flanagan D, Vincan E (2016). Frizzled7: a promising achilles' heel for targeting the Wnt Receptor complex to treat cancer. Cancers (Basel) 8: 50.
154. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC (2000). An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407: 535–538.
155. Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM et al. (2012). Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene 31: 2725–2737.
156. Rhee C-S, Sen M, Lu D, Wu C, Leoni L, Rubin J et al. (2002). Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21: 6598–6605.
157. Riggleman B, Schedl P, Wieschaus E, Baker NE, Baker NE, Baker NE et al. (1990). Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless. Cell 63: 549–560.
158. De Robertis M, Arigoni M, Loiacono L, Riccardo F, Calogero RA, Feodorova Y et al. (2015) Novel insights into Notum and glypicans regulation in colorectal cancer. Oncotarget 6: 41237–41257.
159. Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM et al. (2015). Integrative clinical genomics of advanced prostate cancer. Cell 161: 1215–1228.
160. Rodriguez J, Esteve P, Weinl C, Ruiz JM, Fermin Y, Trousse F et al. (2005). SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor. Nat Neurosci 8: 1301–1309.
161. Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P et al. (1998). The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 395: 608–612.
162. Rubin JS, Barshishat-Kupper M, Feroze-Merzoug F, Xi ZF (2006). Secreted WNT antagonists as tumor suppressors: pro and con. Front Biosci 11: 2093–2105.
163. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain S, Masiarz F et al. (1993). Association of the APC gene product with beta-catenin. Science 262: 1731–1734.
164. Ryan JF, Pang K, Schnitzler CE, Nguyen A-DD, Moreland RT, Simmons DK et al. (2013). The genome of the ctenophore Mnemiopsis leidyi and its implications for cell type evolution. Science 342.
165. Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE et al. (2013). RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol 229: 469–476.
166. Sanchez-Pulido L, Ponting CP (2013). Tiki, at the head of a new superfamily of enzymes. Bioinformatics 29: 2371–2374.
167. Schulte G (2015). Frizzleds and WNT/beta-catenin signaling--The black box of ligand-receptor selectivity, complex stoichiometry and activation kinetics. Eur J Pharmacol 763: 191–195.
168. Seaman MNJ (2012). The retromer complex – endosomal protein recycling and beyond. J Cell Sci 125: 4693–4702.
169. Seifert JRK, Mlodzik M (2007). Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet 8: 126–138.
170. Semenov M, Tamai K, He X (2005). SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280: 26770–26775.
171. Semenov MV, Tamai K, Brott BK, Kohl M, Sokol S, He X (2001). Head inducer dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11: 951–961.
172. Semenov MV, Zhang X, He X (2008). DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem 283: 21427–21432.
173. Serru V, Dessen P, Boucheix C, Rubinstein E (2000). Sequence and expression of seven new tetraspans. Biochim Biophys Acta-Protein Struct Mol Enzymol 1478: 159–163.
174. Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB et al. (2012). Recurrent R-spondin fusions in colon cancer. Nature 488: 660–664.
175. Shinmura K, Kahyo T, Kato H, Igarashi H, Matsuura S, Nakamura S et al. (2014). RSPO fusion transcripts in colorectal cancer in Japanese population. Mol Biol Rep 41: 5375–5384.
176. Siegfried E, Chou TB, Perrimon N (1992). wingless signaling acts through zeste-white 3, the drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. Cell 71: 1167–1179.
177. Smith DC, Rosen LS, Chugh R, Goldman JW, Xu L, Kapoun A et al. (2013). First-in- human evaluation of the human monoclonal antibody vantictumab (OMP-18R5; anti-Friz- zled) targeting the WNT pathway in a phase I study for patients with advanced solid tumors. In ASCO Annual Meeting, p.
178. Smolich BD, McMahon JA, McMahon AP, Papkoff J (1993). Wnt family proteins are secreted and associated with the cell surface. Mol Biol Cell 4: 1267–1275.
179. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44 (Database Issue): D1054–1068.
180. Srivastava M, Begovic E, Chapman J, Putnam NH, Hellsten U, Kawashima T et al. (2008). The Trichoplax genome and the nature of placozoans. Nature 454: 955–960.
181. Su L, Vogelstein B, Kinzler K (1993). Association of the APC tumor suppressor protein with catenins. Science 262: 1734–1737.
182. Suzuki H, Watkins DN, Jair K-W, Schuebel KE, Markowitz SD, Chen WD et al. (2004). Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417–422.
183. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondoh H et al. (2006). Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 11: 791–801.
184. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y et al. (2000). LDL-receptor-related proteins in Wnt signal transduction. Nature 407: 530–535.
185. Tanaka K, Kitagawa Y, Kadowaki T (2002). Drosophila segment polarity gene product porcupine stimulates the posttranslational N-glycosylation of wingless in the endoplasmic reticulum. J Biol Chem 277: 12816–12823.
186. Tanaka S, Akiyoshi T, Mori M, Wands JR, Sugimachi K (1998). A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A 95: 10164–10169.
187. Tang Y, Simoneau AR, Liao W, Yi G, Hope C, Liu F et al. (2009). WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells. Mol Cancer Ther 8: 458–468.
188. Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kumon H et al. (2007). REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 19: 363–368.
189. Thorpe CJ, Schlesinger A, Clayton Carter J, Bowerman B (1997). Wnt signaling polarizes an early C. elegans blastomere to distinguish endoderm from mesoderm. Cell 90: 695–705.
190. Torisu Y, Watanabe A, Nonaka A, Midorikawa Y, Makuuchi M, Shimamura T et al. (2008). Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by β-catenin/TCF. Cancer Sci 99: 1139–1146.
191. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M (2000). A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20–24.
192. Tsuji T, Nozaki I, Miyazaki M, Sakaguchi M, Pu H, Hamazaki Y et al. (2001). Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun 289: 257–263.
193. Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H et al. (2009). Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer 101: 1374–1381.
194. Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, Tabatabai ZL et al. (2012). Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther 11: 244–253.
195. Üren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP et al. (2000). Secreted frizzled-related protein-1 binds directly to wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275: 4374–4382.
196. Veeck J, Wild PJ, Fuchs T, Schüffler PJ, Hartmann A, Knüchel R et al. (2009). Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer 9: 217.
197. Vincan E, Darcy PK, Farrelly CA, Faux MC, Brabletz T, Ramsay RG (2007). Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids. Oncogene 26: 2340–2352.
198. Vincan E, Darcy PK, Smyth MJ, Thompson EW, Thomas RJS, Phillips WA et al. (2005). Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation 73: 142–153.
199. Vincent JP, Dubois L (2002). Morphogen transport along epithelia, an integrated trafficking problem. Dev Cell 3: 615–623.
200. Wang D, Huang B, Zhang S, Yu X, Wu W, Wang X (2013). Structural basis for R-spondin recognition by LGR4/5/6 receptors. Genes Dev 27: 1339–1344.
201. Wang K, Yuen ST, Xu J, Lee SP, Yan HHN, Shi ST et al. (2014). Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet 46: 573–582.
202. Wang K, Zhang Y, Li X, Chen L, Wang H, Wu J et al. (2008). Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism. J Biol Chem 283: 23371–23375.
203. Wang S, Krinks M, Lin K, Luyten FP, Moos M (1997). Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell 88: 757–766.
204. Wang Y, Nathans J (2007). Tissue/planar cell polarity in vertebrates: new insights and new questions. Development 134: 647–658.
205. Watson AL, Rahrmann EP, Moriarity BS, Choi K, Conboy CB, Greeley AD et al. (2013). Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance. Cancer Discov 3: 675–689.
206. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D et al. (2000). arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527–530.
207. Wei W, Chua M-S, Grepper S, So SK (2011). Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer 10: 16.
208. Weidinger G, Thorpe CJ, Wuennenberg-Stapleton K, Ngai J, Moon RT (2005). The Sp1-related transcription factors sp5 and sp5-like act downstream of Wnt/β-catenin signaling in mesoderm and neuroectoderm patterning. Curr Biol 15: 489–500.
209. Van de Wetering M, Cavallo R, Dooijes D, Van Beest M, Van Es J, Loureiro J et al. (1997). Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789–799.
210. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T et al. (2003). Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423: 448–452.
211. Witkiewicz AK, McMillan EA, Balaji U, Baek G, Lin W-C, Mansour J et al. (2015). Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun 6: 6744.
212. Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD et al. (2011). Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 108: 21188–21193.
213. Wu W, Glinka A, Delius H, Niehrs C (2000). Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/β-catenin signalling. Curr Biol 10: 1611–1614.
214. Xie Y, Zamponi R, Charlat O, Ramones M, Swalley S, Jiang X et al. (2013). Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin. EMBO Rep 14: 1120–1126.
215. Xu K, Xu Y, Rajashankar KR, Robev D, Nikolov DB (2013). Crystal structures of Lgr4 and its complex with R-Spondin1. Structure 21: 1683–1689.
216. Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C et al. (2004). Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116: 883–895.
217. Xu R, Zeng S, Xie W, Sun C, Chen YL, Chen MJ et al. (2016). The expression and function of Frizzled-7 in human renal cell carcinoma. Clin Transl Oncol 18: 269–276.
218. Yaccoby S, Ling W, Zhan F, Walker R, Barlogie B, Shaughnessy JD (2007). Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood 109: 2106–2111.
219. Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan Y-C et al. (2011). FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene 30: 4437–4446.
220. Yoshino K, Rubin JS, Higinbotham KG, Uren A, Anest V, Plisov SY et al. (2001). Secreted Frizzled-related proteins can regulate metanephric development. Mech Dev 102: 45–55.
221. Zebisch M, Xu Y, Krastev C, MacDonald BT, Chen M, Gilbert RJC et al. (2013). Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun 4: 2787.
222. Zecca M, Basler K, Struhl G (1996). Direct and long-range action of a wingless morphogen gradient. Cell 87: 833–844.
223. Zhai L, Chaturvedi D, Cumberledge S (2004). Drosophila Wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine. J Biol Chem 279: 33220–33227.
224. Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin S et al. (2011). Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2: 554.
225. Zhang X, Abreu JG, Yokota C, MacDonald BT, Singh S, Coburn KLA et al. (2012). Tiki1 is required for head formation via wnt cleavage-oxidation and inactivation. Cell 149: 1565–1577.
226. Zhang X, MacDonald BT, Gao H, Shamashkin M, Coyle AJ, Martinez RV et al. (2016). Characterization of tiki, a new family of wnt-specific metalloproteases. J Biol Chem 291: 2435–2443.
227. Zhou Y, Nathans J (2014). Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical Wnt signaling. Dev Cell 31: 248–256.